Cochrane Abstracts
Long‐acting beta2‐agonists for bronchiectasis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Beta2‐agonists for Bronchiectasis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440156/all/Long‐acting_beta2‐agonists_for_bronchiectasis.
Long‐acting beta2‐agonists for bronchiectasis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440156/all/Long‐acting_beta2‐agonists_for_bronchiectasis. Accessed November 21, 2024.
Long‐acting beta2‐agonists for bronchiectasis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440156/all/Long‐acting_beta2‐agonists_for_bronchiectasis
Long‐acting Beta2‐agonists for Bronchiectasis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440156/all/Long‐acting_beta2‐agonists_for_bronchiectasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting beta2‐agonists for bronchiectasis
ID - 440156
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440156/all/Long‐acting_beta2‐agonists_for_bronchiectasis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
